Point-of-Care Glucose Testing Market Research Reveals Path To $6.95 Billion By 2030

The point-of-care glucose testing market is on a promising growth trajectory, driven by advances in technology and evolving patient needs. As healthcare increasingly embraces digital solutions, this sector is positioned to expand significantly over the coming years. The following overview dives into the market's projected growth, key players, emerging trends, and segmentation insights shaping its future.

Forecasted Expansion in the Point-of-Care Glucose Testing Market Size
The market for point-of-care glucose testing is anticipated to grow substantially, reaching a valuation of $6.95 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 6.3%. Factors contributing to this expansion include the rising use of connected glucose monitoring devices, deeper integration with mobile health apps, growing demand for non-invasive testing options, and the increasing deployment of remote patient monitoring programs. Additionally, a stronger focus on personalized diabetes care is expected to further propel market growth. Key trends to watch during the forecast period are the rising popularity of Bluetooth-enabled glucose meters, increased adoption of continuous glucose monitoring (CGM) devices, preference for home-based glucose testing, growth of digital diabetes management platforms, and an enhanced emphasis on patient-led self-monitoring.

The point-of-care glucose testing market size has grown strongly in recent years. It will grow from $5.14 billion in 2025 to $5.44 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to rising prevalence of diabetes, increased adoption of self-monitoring practices, availability of affordable glucose meters, expansion of outpatient diabetes care, growing awareness of glycemic control.

Download a free sample of the point-of-care glucose testing market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Key Players Steering the Point-of-Care Glucose Testing Industry
Several prominent companies dominate the competitive landscape of point-of-care glucose testing. Leading names include F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Siemens Healthineers, TaiDoc Technology Corporation, and Nipro Corporation. Other notable players are Dexcom Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, and Trividia Health Inc. Additional firms such as Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc., and Medtronic plc also contribute significantly to the market.

Strategic Acquisition by Roche Enhances Market Position
In August 2024, F. Hoffmann-La Roche AG, headquartered in Switzerland, expanded its diagnostics portfolio through the acquisition of Point of Care technology from UK-based LumiraDx Ltd. The financial terms of the deal were not disclosed. This acquisition strengthens Roche's capabilities by adding a multifunctional platform that supports several tests on a single device, advancing decentralized healthcare solutions. LumiraDx Ltd. specializes in point-of-care diagnostic products, including glucose testing systems.

View the full point-of-care glucose testing market report:
https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR

Emerging Technologies and Future Directions in the Point-of-Care Glucose Testing Market
Leading industry players are focusing on breakthroughs such as wearable continuous glucose monitoring systems equipped with predictive analytics. These innovations aim to improve real-time glucose tracking, enhance glycemic management, and reduce the reliance on manual testing. Continuous glucose monitoring systems use a small sensor implanted beneath the skin to measure glucose levels in the interstitial fluid continuously. This data is transmitted to a mobile application, enabling users to manage their condition proactively with real-time alerts and forecasted trends. For example, in July 2024, Roche introduced the Accu-Chek SmartGuide CGM system designed for diabetes patients. This product offers glucose readings every five minutes, AI-driven trend predictions up to two hours in advance, overnight hypo- and hyperglycemia alerts, and seamless mobile app connectivity for detailed data tracking and remote health monitoring. These features provide a safer and more convenient alternative to traditional finger-prick glucose meters.

Detailed Segmentation of the Point-of-Care Glucose Testing Market
The market is categorized into several segments to address diverse product types, testing sites, applications, and end-users:

1) By Product:
- Lancet and Lancing Devices
- Strips
- Meters

2) By Testing Site:
- Fingertips
- Alternate Site Testing

3) By Applications:
- Type-1 Diabetes
- Type-2 Diabetes

4) By End-User:
- Professional Diagnostic Centers
- Hospitals and Clinics
- Home Care Settings
- Other End Users

Further subdivisions include:
- Lancet and Lancing Devices: single-use lancets, multi-use lancets, and adjustable lancing devices
- Strips: glucose test strips, ket*one test strips, and combination strips for glucose and ket*one
- Meters: blood glucose meters, continuous glucose monitoring (CGM) meters, and Bluetooth-enabled meters

This comprehensive segmentation reflects the diverse needs and usage scenarios within the point-of-care glucose testing market, supporting tailored solutions for patients and healthcare providers alike.

The 2026 edition of our market reports now delivers enhanced analytical coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.